Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Crit Rev Oncol Hematol ; 157: 103166, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33254039

RESUMEN

Cell-free DNA (cfDNA) as an emerging biomarker with huge potential for clinical application, especially in the field of liquid biopsy. The field is now in a critical transitional period in which cfDNA-based analysis is developing rapidly. No doubt learning more about the biological knowledge of cfDNA is beneficial to catalyze this transformation process. Therefore, in this review we have summarized the characteristics of cfDNA, including its structure and origin of tissues, in order to provide researchers with a more holistic insight of cfDNA. Subsequently, we focused on the pathways that cfDNA releases from cells, such as apoptosis, necrosis, and active secretion. Additionally, the clearance of cfDNA derived from both cellular death and active secretion in the physiological environment is also discussed. Finally, we have mentioned the link between cfDNA active secretion and tumor microenvironment.


Asunto(s)
Ácidos Nucleicos Libres de Células , Apoptosis/genética , Biomarcadores de Tumor , Secreciones Corporales , Humanos , Biopsia Líquida , Necrosis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA